Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Iridex launches new IQ 577 laser systems
According to Iridex, the IQ 577 is a high-power, true yellow laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular
According to Iridex, the IQ 577 is a high-power, true yellow laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular
The company has already expressed virus like particles (VLP) of the following pandemic strains in plants: Singapore (H2N2), Anhui (H5N1), Vietnam (H5N1), Hong Kong (H6N1 and H9N2), Equine/Prague
Definitive LE is a prospective, multi-center, single-arm study to evaluate the intermediate and long-term effectiveness of stand-alone SilverHawk plaque excision therapy for endovascular treatment of lower extremity peripheral
Dr Koos is the developer of a screening test for gestational diabetes licensed to Entest BioMedical by University of California, Los Angeles (UCLA). The screening test is believed
Socrate Medical will market the CT Laser Mammography (CTLM) system to the private and public sector of these regions. Imaging Diagnostic Systems said that it will continue to
Pacgen Biopharmaceuticals, a life sciences company, has announced that, as part of its process to restructure the company, it has signed a letter of intent pursuant to which
Ameritox’s patented Rx Guardian methodology is said to be the only pain medication monitoring process that uses a patented methodology to help physicians assess whether patients are taking
Impulse Monitoring will provide Nash Health Care with comprehensive intraoperative neurophysiological monitoring (IONM) services, including real-time professional oversight by experienced physicians. IONM assesses neurological function involving the brain,
PeriGen said that its name change reflects the company’s evolution into a technology-enabled, professional services company, building on the combined strengths of technology and advanced clinical risk reduction
The appointment of Mr Friel to chairman is believed to be part of PerkinElmer’s 2007 leadership succession plan designed to support the company’s growth strategy and provide strong